1Capello D, Rasi S, Oreste P, et al. Molecular characterization of post - transplant lymphoproliferative disorders of donor origin oc- curring in liver transplant recipients[ J]. J Pathol,2009,218 (4) : 478 - 486.
2Jiang Y, Villeneuve P J, Fenton S S, et al. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study[ J]. Liver Transpl, 2008,14( 11 ) : 1588 - 1597.
3Costes - Martineau V, Delfour C, Obled S, et al. Anaplastic lym- phoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review [ J ]. J Clin Patho1,2002,55 ( 11 ) :868 - 871.
4Aberg F, Pukkala E, HSckerstedt K, et al. Risk of malignant neo- plasms after liver transplantation : a population - based study [J]. Liver Transpl, 2008,14 (10) : 1428 - 1436.
5Tsai D E, Hardy C L,Tomaszewski J E,et al. Reductionin immuno- suppressionas initial therapy for posttransplant lympophproliferativedisorder: analysis of prognostic variables and long- term fbllow - up of 42 adult patients [ J ]. Transplantation, 2001,71 ( 8 ) : 1076 - 1088.
